Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
are the largest academic unit at Rutgers–Camden, delivering a wide array of degree programs at the baccalaureate, master’s, and doctoral levels in the humanities, natural sciences, social sciences, and fine arts
-
are the largest academic unit at Rutgers–Camden, delivering a wide array of degree programs at the baccalaureate, master’s, and doctoral levels in the humanities, natural sciences, social sciences, and fine arts
-
their goals and fosters collaboration among employees. Rutgers–Camden is recognized as a national model for civically engaged urban universities and was selected by the Carnegie Foundation for the Advancement
-
are the largest academic unit at Rutgers–Camden, delivering a wide array of degree programs at the baccalaureate, master’s, and doctoral levels in the humanities, natural sciences, social sciences, and fine arts
-
Services Department UBHC - Inpatient/CTR Overview Rutgers University Behavioral Health Care (UBHC), established in 1971, offers a full continuum of evidence based behavioral health and addiction services
-
, Rutgers University. These positions are funded by research grants from the National Institutes of Health (NIH). Dr. Zhu’s research team focuses on modeling studies of small-molecule drugs, nanomaterials
-
& Molecular Overview New Jersey’s academic health center, Rutgers Biomedical and Health Sciences (RBHS) takes an integrated approach to educating students, providing clinical care, and conducting research, all
-
employees. Rutgers–Camden is recognized as a national model for civically engaged urban universities and was selected by the Carnegie Foundation for the Advancement of Teaching for a Community Engagement
-
Overview The Rutgers Institute for Nicotine and Tobacco Studies (formerly Rutgers Center for Tobacco Studies) is undergoing dynamic and transformative growth. The Rutgers Institute for Nicotine and Tobacco
-
, Rutgers University. These positions are funded by research grants from the National Institutes of Health (NIH). Dr. Zhu’s research team focuses on modeling studies of small-molecule drugs, nanomaterials